Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s12471-020-01429-7 http://scihub22266oqcxt.onion/10.1007/s12471-020-01429-7 C7189353!7189353 !32350818     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\32350818 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Neth+Heart+J 2020 ; 28 (7-8 ): 406-409 Nephropedia Template TP {{tp|p=32350818 |t=2020. Chloroquine-induced QTc prolongation in COVID-19 patients |pdf=|usr=}}{{32350818 }} gab.com Text Chloroquine-induced QTc prolongation in COVID-19 patients JO: Neth Heart J http://www.kidney.de/pget.php?&tw=1&pmid=32350818 #FOAvip BACKGROUND: In the battle against the SARS-CoV?2 pandemic, chloroquine has emerged as a new potential therapeutic option for the treatment of infected patients. A safety consideration for the application of chloroquine is its QTc-prolonging potential. Thus far, no data are available on the QTc-prolonging potential of chloroquine in COVID-19 patients. OBJECTIVE: To assess the degree of chloroquine-induced QTc prolongation in hospitalised COVID-19 patients. METHODS: A baseline electrocardiogram (ECG) and ECGs recorded during chloroquine treatment were retrospectively collected in patients suspected of having COVID-19. The QTc interval was calculated by computerised and manual interpretation. Baseline and follow-up QTc intervals were compared using the paired samples t-test. RESULTS: A total of 95 patients had a baseline ECG recording and at least one ECG recording during chloroquine therapy. Chloroquine treatment resulted in a mean QTc prolongation of 35?ms (95% CI 28-43?ms) using computerised interpretation and 34?ms (95% CI 25-43?ms) using manual interpretation. No torsade de pointes was observed during chloroquine treatment. After manual review, 22 patients (23%) had a QTc interval exceeding 500?ms during chloroquine treatment. None of these patients had a prolonged QTc interval prior to the initiation of chloroquine treatment. CONCLUSIONS: Chloroquine significantly prolongs the QTc interval in a clinically relevant matter. This highlights the need for ECG monitoring when prescribing chloroquine to COVID-19 patients. Twit Text FOAVip Chloroquine-induced QTc prolongation in COVID-19 patients ????Neth Heart J http://www.kidney.de/pget.php?&tw=1&pmid=32350818 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32350818 #FOAvip English Wikipedia <ref>{{Cite pmid|32350818 }}</ref> Chloroquine-induced QTc prolongation in COVID-19 patients #MMPMID32350818 van den Broek MPH ; Möhlmann JE ; Abeln BGS ; Liebregts M ; van Dijk VF ; van de Garde EMW Neth Heart J 2020[Jul]; 28 (7-8 ): 406-409 PMID32350818 show ga BACKGROUND: In the battle against the SARS-CoV?2 pandemic, chloroquine has emerged as a new potential therapeutic option for the treatment of infected patients. A safety consideration for the application of chloroquine is its QTc-prolonging potential. Thus far, no data are available on the QTc-prolonging potential of chloroquine in COVID-19 patients. OBJECTIVE: To assess the degree of chloroquine-induced QTc prolongation in hospitalised COVID-19 patients. METHODS: A baseline electrocardiogram (ECG) and ECGs recorded during chloroquine treatment were retrospectively collected in patients suspected of having COVID-19. The QTc interval was calculated by computerised and manual interpretation. Baseline and follow-up QTc intervals were compared using the paired samples t-test. RESULTS: A total of 95 patients had a baseline ECG recording and at least one ECG recording during chloroquine therapy. Chloroquine treatment resulted in a mean QTc prolongation of 35?ms (95% CI 28-43?ms) using computerised interpretation and 34?ms (95% CI 25-43?ms) using manual interpretation. No torsade de pointes was observed during chloroquine treatment. After manual review, 22 patients (23%) had a QTc interval exceeding 500?ms during chloroquine treatment. None of these patients had a prolonged QTc interval prior to the initiation of chloroquine treatment. CONCLUSIONS: Chloroquine significantly prolongs the QTc interval in a clinically relevant matter. This highlights the need for ECG monitoring when prescribing chloroquine to COVID-19 patients. äChloroquine-induced QTc prolongation in COVID-19 patients (epmc).pdf DeepDyve Pubget Overpricing